Pharmaceutical company Corona Remedies, which is backed by private equity firm ChrysCapital, on Wednesday set a price range of Rs 1,008-1,062 per share for its upcoming initial public offering (IPO), valuing the company at nearly Rs 6,500 crore. The initial public offer of Rs 655.37 crore, which is entirely an Offer For Sale (OFS) by […]
Et Intelligence Group: The stock of Granules India has shown a marginal recovery of 5% since 11 August, despite lower absolute profit and margins reported by the pharmaceutical company in the quarter of June. This has also reduced its loss of one month on the Bourses to around 7%. Investor optimism depends on the strong […]